| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |